Teva Pharmaceutical Industries Ltd. (TEVA) announced that it has appointed Carlo De Notaristefani as President and Chief Executive Officer of Global Operations.
De Notaristefani has over 25 years of international experience with extensive technical, operational, manufacturing and P&L experience. Recently, De Notaristefani was at Bristol Myers Squibb (BMS) where he served as President, Technical Operations and Global Support Functions.
The company also appointed Aharon Yaari as the Executive Vice President to the newly created organization, Community and Institutional Affairs. Yaari joined Teva in 1981, and has served in significant key positions at Teva, such as Group Vice President, Global API, and most recently as Group Vice President, Teva Generics Systems.
In addition, as part of its strategic objectives, Teva has established an organization of Community and Institutional Affairs. This organization will be led by Yaari who will execute on Teva's global commitment to social responsibility, philanthropy, institutional affairs and academic relations.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.